Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model.
about
A critical assessment of boron target compounds for boron neutron capture therapy.Ligand liposomes and boron neutron capture therapy.Gd@C82 metallofullerenes for neutron capture therapy-fullerene solubilization by poly(ethylene glycol)-block-poly(2-(N, N-diethylamino)ethyl methacrylate) and resultant efficacy in vitro.Boron as a platform for new drug design.Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective.Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy.Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy.Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy.In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agent.Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy.EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.Synthesis and Applications of Perfunctionalized Boron Clusters.Lipid-membrane-incorporated arylboronate esters as agents for boron neutron capture therapy.Nuclisome--targeting the tumor cell nucleus.Preparation and characterization of liposomal systems entrapping the boronated compound o-carboranylpropylamine.Development of Albumin-closo -Dodecaborate Conjugates as Boron Carriers for Neutron-Capture Therapy by Ru(bpy)3 -Photocatalyzed Modification of Tyrosine
P2860
Q35128593-062DB811-9463-4379-8C0E-98F0CF085933Q35128595-CE3F8079-0C8D-4A16-AFB0-53DE7E0645D7Q37386649-149444FF-359F-42EB-8BCB-3D0BD18B419CQ38040432-E3CF3A85-452F-481B-B8AD-FBB3A366FF7BQ38101626-0AA99220-B55C-46FD-A655-69B7C29BB5E2Q38960391-D6D445F6-45C8-4C96-9490-1973C739AF8FQ39714480-79A3EBEB-71B0-43DB-A30E-B214871E1BDDQ40244248-C9173971-110C-4FF0-932C-C04BF2548D00Q41064675-6F045696-4244-4538-9014-17596EAD74EEQ47218298-9845F6C6-ED6C-41F3-9A00-A42BD388E9EBQ48690139-379B22BA-9592-4317-97BB-8D113AED6E33Q49714896-D37F7288-5D6A-4FD1-8E64-82BA5F94B211Q51105136-17937703-F69D-4341-9D4F-C61E42CCA5DEQ54532261-4F7C8B76-C843-4495-B9CB-D8ACCBA03818Q55476654-04AC98A4-21C2-4256-99D0-F60C13DABB82Q58615055-0F6A94C7-A0F2-4D1B-9649-C91005821F06
P2860
Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Application of boronated anti- ...... neutron capture therapy model.
@ast
Application of boronated anti- ...... neutron capture therapy model.
@en
type
label
Application of boronated anti- ...... neutron capture therapy model.
@ast
Application of boronated anti- ...... neutron capture therapy model.
@en
prefLabel
Application of boronated anti- ...... neutron capture therapy model.
@ast
Application of boronated anti- ...... neutron capture therapy model.
@en
P2093
P2860
P356
P1476
Application of boronated anti- ...... neutron capture therapy model.
@en
P2093
Kobayashi H
Nariuchi H
Sekiguchi M
Takahashi T
P2860
P2888
P304
P356
10.1038/BJC.1991.124
P407
P577
1991-04-01T00:00:00Z
P5875
P6179
1025129395